Allen R. Nissenson's most recent trade in Rockwell Medical Inc was a trade of 50,000 Common Stock done . Disclosure was reported to the exchange on May 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rockwell Medical Inc | Allen R. Nissenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 50,000 | 142,597 (0%) | 0% | 0 | Common Stock | |
| Elicio Therapeutics Inc. | Allen R. Nissenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 7,900 | 7,900 | - | - | Stock Option (Right to Buy) | |
| Elicio Therapeutics Inc. | Allen R. Nissenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2024 | 4,100 | 4,100 | - | - | Stock Option (Right to Buy) | |
| Rockwell Medical Inc | Allen R. Nissenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 36,111 | 92,597 (0%) | 0% | 0 | Common Stock | |
| Elicio Therapeutics Inc. | Nissenson Allen R. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Dec 2023 | 4,100 | 4,100 | - | - | Stock Option (right to buy) | |
| Rockwell Medical Inc | Allen R. Nissenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 24,715 | 124,203 (0%) | 0% | 0 | Common Stock | |
| Rockwell Medical Inc | Allen R. Nissenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 25,000 | 99,488 (0%) | 0% | 0 | Common Stock | |
| Rockwell Medical Inc | Allen R. Nissenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 72,857 | 72,857 | - | - | Stock Option (Right to Buy) | |
| Rockwell Medical Inc | Allen R. Nissenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 50,000 | 74,488 (0%) | 0% | 0 | Common Stock | |
| Rockwell Medical Inc | Allen R. Nissenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2020 | 1,488 | 24,488 (0%) | 0% | 0 | Common Stock |